Cytek Biosciences Inc — Quarterly Financial Statistics (NASDAQ:CTKB) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 13.22 M2 M125 K-108 K3.9 M771 K 4.69 M Cash from investing activities 15.81 M63.43 M9.45 M-2.49 M5 M-1.84 M 10.12 M Cash from financing activities 12.08 M3.64 M11.54 M2.6 M-1.94 M1.23 M 13.43 M Free cash flow 12.22 M1.09 M-726 K-1.76 M3.24 M-262 K 496 K

Nachrichten

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences earnings missed by $0.32, revenue topped estimates

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:CTKB) 2026-01-15

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB)

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Beyond Meat (NASDAQ:BYND), Avadel Pharmaceuticals (NASDAQ:AVDL)

Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates

Cytek Biosciences: EPS verfehlt Schätzungen um 0,01 $ - Umsatz besser als erwartet

Alvotech (ALVO) Surges 8.6%: Is This an Indication of Further Gains?

Cytek Biosciences auf Morgan Stanley Konferenz: Mit Innovationen gegen Marktherausforderungen